Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,172 papers from all fields of science
Search
Sign In
Create Free Account
RRx-001
Known as:
Radiosensitizer RRx-001
A dinitroazetidine derivative with potential radiosensitizing activity. Upon administration, RRx-001 is able to dilate blood vessels, thereby…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Azetidines
Nitro Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Two Case Reports of Resensitization to Previous Chemotherapy with the Novel Hypoxia-Activated Hypomethylating Anticancer Agent RRx-001 in Metastatic Colorectal Cancer Patients
Tony R Reid
,
S. Dad
,
Ron Korn
,
B. Oronsky
,
Susan J. Knox
,
J. Scicinski
Case Reports in Oncology
2014
Corpus ID: 1643276
The development of chemoresistance is a persistent problem during the treatment of cancer. Although reversion or modification of…
Expand
Review
2006
Review
2006
Design of hypoxia-targeting drugs as new cancer chemotherapeutics.
H. Nagasawa
,
Y. Uto
,
K. Kirk
,
H. Hori
Biological and Pharmaceutical Bulletin
2006
Corpus ID: 8028835
The tumor microenvironment is now recognized as a major factor that influences not only the response to conventional anti-cancer…
Expand
1997
1997
Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
H. Hori
,
C. Jin
,
M. Kiyono
,
S. Kasai
,
M. Shimamura
,
S. Inayama
Bioorganic & Medicinal Chemistry
1997
Corpus ID: 1821780
1992
1992
Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
S. Cole
,
I. Stratford
,
+5 authors
Judith Sebolt-Leopold
International Journal of Radiation Oncology…
1992
Corpus ID: 9409338
Highly Cited
1986
Highly Cited
1986
The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
I. Stratford
,
J. Walling
,
A. Silver
British Journal of Cancer
1986
Corpus ID: 2876171
The hypoxic cell radiosensitizer RSU 1069 (1-(2-nitro-1-imidazolyl)-3-(1-aziridinyl)-2-propanol) shows, on a concentration basis…
Expand
Highly Cited
1984
Highly Cited
1984
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508.
C.Norman Coleman
,
Raul C. Urtasun
,
+4 authors
V. Hirst
International Journal of Radiation Oncology…
1984
Corpus ID: 34319576
1983
1983
Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole.
D. Jette
,
L. Wiebe
,
J. Chapman
International Journal of Nuclear Medicine and…
1983
Corpus ID: 33545448
1982
1982
In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administration.
M. Williams
,
J. Denekamp
,
A. Minchinton
,
M. Stratford
International Journal of Radiation Oncology…
1982
Corpus ID: 43217676
1976
1976
The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
J. Denekamp
,
S. R. Harris
Radiation Research
1976
Corpus ID: 41469531
The response of transplantable mammary carcinoma in CBA mice to single doses and two or five fractions of x rays, with and…
Expand
1976
1976
The response of a transplantable tumor to fractionated irradiation. II. Fast neutrons.
J. Denekamp
,
S. R. Harris
,
C. Morris
,
S. B. Field
Radiation Research
1976
Corpus ID: 20624143
A transplantable murine carcinoma has been used to compare the relative effect of single doses, 2 and 5 fractions of x rays, and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE